HOME >> MEDICINE >> NEWS
Prostate treatment decisions based on perception more than fact

Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review. Published in the May 1, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the review of studies in prostate cancer decision making suggests that a lack of medical evidence and consistent, comprehensive messages about therapeutic options compel men to turn to a wide variety of popular and biased sources, which influence their decision. This approach often results in treatments that do not generally reflect patients' goals.

Despite new treatment options for prostate cancer, there is little evidence-based consensus in the oncology community about the most efficacious treatment. Newly diagnosed patients must still balance existing information about risks and benefits of available therapies with their own treatment objectives. Studies have shown that prostate cancer treatment varies not only among men in general but also by race and ethnicity, suggesting that the guidance patients receive is variable and confusing, and plays a part in their decision-making. Steven B. Zeliadt, Ph.D., M.P.H., of the Fred Hutchinson Cancer Center in Seattle and colleagues synthesized data from other studies to examine how and why men with prostate cancer make treatment decisions.

The review of current literature shows that cancer eradication or control was the foremost objective of treatment for men. Minimizing side effects ultimately played a minor role in decision making. However, studies report a gap between patient treatment objectives and the evidence supporting the efficacy of the treatment chosen. Men's concerns about controlling "the cancer" correlated directly with the aggressiveness of the treatment they chose, regardless of actual disease severity. Yet, in choosing treatment, patients did not consistently rely on scientific evidence of a therapy's efficacy to cont
'"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
27-Mar-2006


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer treatment increases risk of diabetes and heart disease
3. Prostate cancer research may be faster with PSA endpoints
4. Prostate cancer test affected by demographic and lifestyle factors
5. Prostate cancer therapy - study suggests new molecular screening theory
6. Spot on treatment for acne
7. New treatment boosts muscle function in myasthenia gravis
8. New treatment effective in counteracting cocaine-induced symptoms
9. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
10. Preventive treatments in elderly people needs rethinking
11. Osteoporosis screening and treatment may be cost-effective for selected older men

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2019)... ... 16, 2019 , ... AdventHealth West Florida Division announced today ... Tampa Bay. Today, the prestigious Leapfrog Group, a national nonprofit health care ratings ... about a third of those hospitals received an “A” grade, including seven in ...
(Date:5/15/2019)... ... May 16, 2019 , ... Statistical Concepts ... p.m. - 3:00 p.m. EDT, https://www.fdanews.com/statisticalconceptsprocessvalidation , Devicemakers: Are the organizations ... or even maybe … Dan O’Leary is here to help. Dan is FDAnews’s ...
(Date:5/14/2019)... ... 15, 2019 , ... Tune in Wednesday, May 15 at 7pm for the Healthy Woman Show ... Excellence highlights bladder control problems that are embarrassing and inconvenient for women. , “We ... and you spend more time away from your home. Our goal is to help ...
(Date:5/14/2019)... ... 2019 , ... The Atlanta Falcons, the Baltimore Ravens and ... the U.S. who rely on HydroWorx aquatic therapy pools to care for their ... healing,” said Timothy McCarthy, Chief Executive Officer for HydroWorx. “Whether it’s for ...
(Date:5/14/2019)... , ... May 14, 2019 , ... ... Dallas, TX, has been named by Modern Healthcare as one of the nation's Best Places to ... has been awarded this title, which comes on the heels of being named ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... ... May 16, 2019 , ... Actuate Therapeutics, Inc., a clinical stage biopharmaceutical ... The Series B is led by Kairos Ventures, with DEFTA Partners, Tech Coast ... the financing to expand the company’s ongoing Phase 1 / 2 clinical trial and ...
(Date:5/16/2019)... ... May 16, 2019 , ... Guruji ... today’s issues affecting humanity at practical and spiritual levels. , Founder of ... connection to the God of their understanding, as well as, to illuminate the ...
(Date:5/16/2019)... ... May 16, 2019 , ... Luma Health ... launched Mobile Patient Intake. This new solution helps providers deliver a top-notch patient ... own convenience, on their device of choice, days or weeks prior to their ...
Breaking Medicine Technology:
Cached News: